186 related articles for article (PubMed ID: 19199361)
1. Weight loss, body fat mass, and leptin in Parkinson's disease.
Lorefält B; Toss G; Granérus AK
Mov Disord; 2009 Apr; 24(6):885-90. PubMed ID: 19199361
[TBL] [Abstract][Full Text] [Related]
2. Does L-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease?
Pålhagen S; Lorefält B; Carlsson M; Ganowiak W; Toss G; Unosson M; Granérus AK
Acta Neurol Scand; 2005 Jan; 111(1):12-20. PubMed ID: 15595933
[TBL] [Abstract][Full Text] [Related]
3. Leptin and ghrelin concentrations and weight loss in Parkinson's disease.
Fiszer U; Michałowska M; Baranowska B; Wolińska-Witort E; Jeske W; Jethon M; Piaścik-Gromada M; Marcinowska-Suchowierska E
Acta Neurol Scand; 2010 Apr; 121(4):230-6. PubMed ID: 20028343
[TBL] [Abstract][Full Text] [Related]
4. A pilot study on the impact of body composition on bone and mineral metabolism in Parkinson's disease.
Fernández MC; Parisi MS; Díaz SP; Mastaglia SR; Deferrari JM; Seijo M; Bagur A; Micheli F; Oliveri B
Parkinsonism Relat Disord; 2007 Aug; 13(6):355-8. PubMed ID: 17292656
[TBL] [Abstract][Full Text] [Related]
5. Factors of importance for weight loss in elderly patients with Parkinson's disease.
Lorefält B; Ganowiak W; Pålhagen S; Toss G; Unosson M; Granérus AK
Acta Neurol Scand; 2004 Sep; 110(3):180-7. PubMed ID: 15285776
[TBL] [Abstract][Full Text] [Related]
6. [Body fat loss in patients with Parkinson's disease].
Sakajiri K; Takamori M
Rinsho Shinkeigaku; 1997 Jul; 37(7):611-4. PubMed ID: 9396358
[TBL] [Abstract][Full Text] [Related]
7. Body composition in advanced-stage Parkinson's disease.
Petroni ML; Albani G; Bicchiega V; Baudo S; Vinci C; Montesano A; Izzo G; Bertocco P; Mazzotta S; Zorzetto E; Balzola F; Mauro A
Acta Diabetol; 2003 Oct; 40 Suppl 1():S187-90. PubMed ID: 14618469
[TBL] [Abstract][Full Text] [Related]
8. Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade).
Sharma JC; Macnamara L; Hasoon M; Vassallo M; Ross I
Parkinsonism Relat Disord; 2006 Dec; 12(8):499-505. PubMed ID: 16935018
[TBL] [Abstract][Full Text] [Related]
9. Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration.
Andreadou E; Nikolaou C; Gournaras F; Rentzos M; Boufidou F; Tsoutsou A; Zournas C; Zissimopoulos V; Vassilopoulos D
Clin Neurol Neurosurg; 2009 Nov; 111(9):724-8. PubMed ID: 19632030
[TBL] [Abstract][Full Text] [Related]
10. Increase in body weight after pramipexole treatment in Parkinson's disease.
Kumru H; Santamaria J; Valldeoriola F; Marti MJ; Tolosa E
Mov Disord; 2006 Nov; 21(11):1972-4. PubMed ID: 16972276
[TBL] [Abstract][Full Text] [Related]
11. Bone mass in elderly patients with Parkinson's disease.
Lorefält B; Toss G; Granérus AK
Acta Neurol Scand; 2007 Oct; 116(4):248-54. PubMed ID: 17824904
[TBL] [Abstract][Full Text] [Related]
12. Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats.
Mathai ML; Naik S; Sinclair AJ; Weisinger HS; Weisinger RS
Int J Obes (Lond); 2008 Oct; 32(10):1576-84. PubMed ID: 18698317
[TBL] [Abstract][Full Text] [Related]
13. Predictors of weight loss in Parkinson's disease.
Uc EY; Struck LK; Rodnitzky RL; Zimmerman B; Dobson J; Evans WJ
Mov Disord; 2006 Jul; 21(7):930-6. PubMed ID: 16534756
[TBL] [Abstract][Full Text] [Related]
14. Anthropometric and leptin changes in women following different dietary approaches to weight loss.
Miller LE; Volpe JJ; Coleman-Kelly MD; Gwazdauskas FC; Nickols-Richardson SM
Obesity (Silver Spring); 2009 Jan; 17(1):199-201. PubMed ID: 18997680
[TBL] [Abstract][Full Text] [Related]
15. Weight loss in Parkinson's disease.
Chen H; Zhang SM; Hernán MA; Willett WC; Ascherio A
Ann Neurol; 2003 May; 53(5):676-9. PubMed ID: 12731005
[TBL] [Abstract][Full Text] [Related]
16. Baseline leptin levels predict change in leptin levels during weight loss in obese breast cancer survivors.
Sen A; Jen KL; Djuric Z
Breast J; 2007; 13(2):180-6. PubMed ID: 17319860
[TBL] [Abstract][Full Text] [Related]
17. Changes in body composition during weight loss in obese client-owned cats: loss of lean tissue mass correlates with overall percentage of weight lost.
German AJ; Holden S; Bissot T; Morris PJ; Biourge V
J Feline Med Surg; 2008 Oct; 10(5):452-9. PubMed ID: 18417397
[TBL] [Abstract][Full Text] [Related]
18. Bioelectric impedance spectroscopy underestimates fat-free mass compared to dual energy X-ray absorptiometry in incurable cancer patients.
Ellegård LH; Ahlén M; Körner U; Lundholm KG; Plank LD; Bosaeus IG
Eur J Clin Nutr; 2009 Jun; 63(6):794-801. PubMed ID: 18478025
[TBL] [Abstract][Full Text] [Related]
19. Anthropometric, metabolic, psychosocial, and dietary characteristics of overweight/obese postmenopausal women with a history of weight cycling: a MONET (Montreal Ottawa New Emerging Team) study.
Strychar I; Lavoie ME; Messier L; Karelis AD; Doucet E; Prud'homme D; Fontaine J; Rabasa-Lhoret R
J Am Diet Assoc; 2009 Apr; 109(4):718-24. PubMed ID: 19328269
[TBL] [Abstract][Full Text] [Related]
20. Levodopa therapy reduces DNA damage in peripheral blood cells of patients with Parkinson's disease.
Cornetta T; Palma S; Aprile I; Padua L; Tonali P; Testa A; Cozzi R
Cell Biol Toxicol; 2009 Aug; 25(4):321-30. PubMed ID: 18523852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
